期刊文献+

Ets-1在大鼠顺铂相关性肾病基质重塑中的作用 被引量:9

Role of Ets-1 in matrix remodeling in cisplatin nephropathy of rats
下载PDF
导出
摘要 目的观察Ets-1、基质金属蛋白酶-1(MMP-1)、基质金属蛋白酶-1组织抑制剂(TIMP-1)和胶原Ⅲ在实验性顺铂相关性肾病中的表达,并探讨其意义。方法6周雄性W istar大鼠被随机分成两组:顺铂组(n=20),顺铂6 mg.kg-1腹腔内单次注射;对照组(n=12),同等剂量生理盐水注射。注射后1、3、7、14 d处死各组动物,每次顺铂组5只,对照组3只。结果顺铂组在顺铂注射后第3、7、14天出现肾功能不全,在第3、7天肾小管上皮细胞出现变性、坏死、凋亡及间质内炎症细胞浸润,第14天可见明显肾间质纤维化形成。与对照组比较,Ets-1在肾小管间质内的表达在顺铂注射后第3天明显增加(P<0.05),第7、14天则明显减少(P<0.01);MMP-1表达呈现相似形式,顺铂注射后第3日明显增加(P<0.01);而TIMP-1表达在顺铂处理后第1、3天无明显变化,第7、14天则明显增加(P<0.01);MMP-1/TIMP-1在顺铂注射后第1天即明显升高(P<0.01),第3天升高更为明显(P<0.001),第7、14天则明显下降,与顺铂注射后第3天相比,差异有统计学意义(P<0.001);胶原Ⅲ沉积在顺铂处理后第7、14天则逐渐增加(P<0.05,P<0.01)。统计学分析显示,肾小管间质内Ets-1表达同MMP-1的表达呈正相关(r=0.78,P<0.01),同TIMP-1的表达呈负相关(r=-0.639,P<0.01),而同MMP-1/TIMP-1呈正相关(r=0.925,P<0.001)。肾小管间质内Ets-1表达与胶原Ⅲ的表达呈负相关(r=-0.599,P<0.01);MMP-1/TIMP-1与胶原Ⅲ的表达呈负相关(r=-0.631,P<0.01)。免疫双染结果表明,Ets-1阳性肾小管上皮细胞同时具有MMP-1阳性表达;肾小管上皮细胞TIMP-1表达增加处肾间质区域内同时存在胶原Ⅲ大量沉积。结论Ets-1转录因子可能通过调节MMP-1与TIMP-1酶系统的平衡,对胶原蛋白在肾间质内沉积产生影响,在顺铂相关性肾病基质重塑过程中起关键性作用。 Objective To study the role of Ets-1, metalloproteinase-1 ( MMP- 1 ), tissue inhibitor of metalloproteinase-1 (TIMP-1 ) and interstitial type Ⅲ collagen in matrix remodeling in experimental cisplatin nephropathy. Methods Six-week-old male Wistar rats ( n = 32) were divided into two groups. Rats in control group (n = 12) injected with normal saline,while rats in cisplatin group (n = 20) were treated with a single intraperitoneal injection of cisplatin (6 mg·kg^-1 ). rats were killed on days 1,3,7 and 14. Results In contrast to kidneys obtained from control rats, kidneys of cisplatin-treated rats showed features of tubular regeneration, necrosis, apoptosis, inflammatory cells infiltration, and occasional dilatation of tubular lumina in eorticomedullary areas on days 3 and 7. In addition, interstitial fibrosis was noted in kidneys obtained from eisplatin-treated rats on day 14. Compared with control rats, Ets-1 positive cells significantly increased in tubular epithelial cells and interstitial cells in the kidneys of eisplatin-treated rats on day 3 ( P 〈 0.05 ), decreased on days 7 ( P 〈 0. 01 ) and 14 (P 〈0.01 ). The expression of MMP-1 on tubulointerstitium showed a similar pattern,significantly increased on day 3 (P 〈0.01 ) in contrast to the same time point of control rat kidneys,but deereased on days 7 (P 〈0.01 ) and 14 (P 〈0.01 ). Compared with control, the expression of TIMP-1 on tubulointerstitium significantly increased ratio of MMP- 1 and TIMP- 1 on days 7 ( P 〈 0.01 ) and 14 ( P 〈 0.01 ). Compared with control rat kidneys, the on tubulointertitium began to increase on day 1 ( P 〈 0.01 ) of cisplatin-treated rat kidneys, and significantly increased on day 3 ( P 〈 0. 001 ). In cisplatintreated rats the ratio of MMP- 1 and TIMP-1 was significantly decreased on days 7 and 14 ,when compared contol rat kindeys,interstitial accumulation of type Ⅲ collagen began with day 3 ( P 〈0.001 ). Compared with to increase on day
出处 《现代医学》 2008年第5期301-305,共5页 Modern Medical Journal
关键词 顺铂相关性肾病 免疫组织化学 ETS-1 基质金属蛋白酶-1 基质金属蛋白酶-1组织抑制剂 胶原Ⅲ cisplatin nephropathy immunohistochemistry Ets-1 metalloproteinase-1 tissue inhibitor of metalloproteinase-1 type Ⅲ collagen
  • 相关文献

参考文献7

  • 1Razzaque M S, Naito T, Taguchi T. Proto-oncogene Ets-1 and the kidney[ J]. Nephron,2001,89( 1 ) : 1-4. 被引量:1
  • 2Catania J M, Chen G, Parrish A R. Role of matrix metalloproteinases irt renal pathophysiologies [ J ]. Am J Physiol Renal Physiol,2007,292 ( 3 ) : F905- F911. 被引量:1
  • 3Tanaka H,Terada Y, Kobayashi T, et al. Expression and function of Ets-1 during experimental acute renal failure in rats [ J ]. J Am Soc Nephrol, 2004,15 ( 12 ) : 3083- 3092. 被引量:1
  • 4Reisdorff J,En-Nia A,Stefanidis I,et al.Transcription factor Ets-1 regulates gelatinase a gene expression in mesangial cells[J].J Am Soc Nephrol,2002,13(6):1568-1578. 被引量:1
  • 5Naito T,Tanihata Y,Nishimura H,et al.Expression of matrix metallopreteinase-9 associated with ets-1 proto-oncogene in rat tubulointerstitial cells[J].Nephrel Dial Transplant,2005,20(11):2333-2348. 被引量:1
  • 6Mizui M,Isaka Y,Takabatake Y,et al.Transcription factor Ets1 is essential for mesangial matrix remodeling[J].Kidney Int,2006,70(2):298-305. 被引量:1
  • 7Ji Z,Degemy C,Vintonenko N,et al.Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation[J].Oncogene,2007,26 (3):395 -406. 被引量:1

同被引文献105

  • 1孙辽,余学清,祝胜郎,陈文芳,李哓艳,贾占军,王欣,窦献蕊,董秀清,孙惠力.AGEs对肾小管上皮细胞转分化、1型胶原合成及smad信号通路的影响[J].中国病理生理杂志,2006,22(12):2429-2433. 被引量:13
  • 2杜兆江,李鹏,惠延年,王百忍,段小莉,张瑞.Ets-1和VEGF在实验性糖尿病视网膜中的共表达(英文)[J].国际眼科杂志,2007,7(2):294-297. 被引量:5
  • 3RAZZAQUE M S,NAITO T,TAGUCHI T.Proto-oncogene Ets-1and the kidney[J].Nephron,2001,89(1):1-4. 被引量:1
  • 4BAILLAT D,LAITEM C,LEPRIVIER C,et al.Ets-1 binds cooperatively to the palindromic Ets-binding sites in the p53 promoter[J].Biochem Biophys Res Commun,2009,378(2):213-217. 被引量:1
  • 5MATHEW S O,VAIDVA S V,KIM J R,et al.Human natural killer cell receptor 2B4(CD244) down-regulates its own expression by reduced promoter activity at an Ets element[J].Biochem Biophys Res Commun,2007,355(2):483-487. 被引量:1
  • 6SONG K S,LEE T J,KIM K,et al.cAMP-responding element-binding protein and c-Ets1 interact in the regulation of ATP-dependent MUC5AC gene expression[J].J Biol Chem,2008,283(40):26869-26878. 被引量:1
  • 7LEFTER L P,DIMA S,SUNAMURA S,et al.Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer[J].Cancer Gene Ther,2009,16(2):137-148. 被引量:1
  • 8FOULDS C E,NELSON M L,BLASZCZAK A G,et al.Ras/Mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment[J].Mol Cell Biol,2004,24(24):10954-10964. 被引量:1
  • 9GROSS C,BUCHWALTER G,DUBOIS-POT H,et al.The ternary complex factor net is downregulated by hypoxia and regulates hypoxia-responsive genes[J].Mol Cell Biol,2007,27(11):4133-4141. 被引量:1
  • 10HIPSKIND R A,BUSCHUER D,NORDHEIM A,et al.Ras/MAP kinase-dependent and-independent signaling pathways target distinct ternary complex factors[J].Genes Dev,1994,8(15):1803-1816. 被引量:1

引证文献9

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部